# InSite Health, Inc. — Form D

InSite Health, Inc. of MARLTON, NJ, a company, filed a Form D exempt-offering notice with the SEC on 2024-02-21. The offering totals $2.9M, of which $2.9M was reported sold. Industry: Other Health Care.

## Offering

- Filed: 2024-02-21
- Form: D
- Accession: 0002012080-24-000001
- Industry: Other Health Care
- Exemptions: 06b
- Total offering: $2.9M
- Amount sold: $2.9M
- Investors: 21
- Date of first sale: 2022-05-27
- Revenue range: Decline to Disclose
- SEC file number: 021-505685

## Issuer

- Name: InSite Health, Inc.
- CIK: 0002012080
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2022
- Address: FIVE GREENTREE CENTER, 525 ROUTE 73, MARLTON, NJ, 08053
- Phone: 833-494-6724

## Officers, directors & promoters (5)

| Name | Role | Location |
| --- | --- | --- |
| Christopher Gaeta | Director | Marlton, NJ |
| Mark Gaeta | Director | Marlton, NJ |
| Stephen Klasko | Director | Marlton, NJ |
| Andrew Zalasin | Director | Marlton, NJ |
| Christopher Gaeta | Executive Officer | Marlton, NJ |

## More

- [CIK 2012080 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=2012080&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0002012080-24-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.